Skip to content
healthcare.dev

ANUBISMED

NDC 83021-750, HA HYALURONIC, cream, from ANUBIS COSMETICS SL.

Product NDC
83021-750
Status
Listed
Labeler
ANUBIS COSMETICS SL
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH FINAL
Application
M016
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83021-750 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALLANTOIN.05 g/50mL
  • ALOE VERA LEAF2.5 g/50mL
  • FRAGRANCE 13576.225 g/50mL
  • GLYCERYL MONOSTEARATE.875 g/50mL
  • TROLAMINE.3 g/50mL
  • BUTYLATED HYDROXYTOLUENE.0535 g/50mL
  • PROPYLENE GLYCOL1.996 g/50mL
  • CETYL ALCOHOL.0038 g/50mL
  • TROPOLONE.004 g/50mL
  • TOCOPHEROL.0004 g/50mL
  • DIMETHICONE.25 g/50mL
  • 1,2-HEXANEDIOL.198 g/50mL
  • IMIDUREA.15 g/50mL
  • CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE.25 g/50mL
  • CETEARYL ETHYLHEXANOATE1.75 g/50mL
  • MEDIUM-CHAIN TRIGLYCERIDES1.5 g/50mL
  • CAPRYLYL GLYCOL.198 g/50mL
  • OCTINOXATE3.4965 g/50mL
  • GLYCERIN.4975 g/50mL
  • GLYCERYL STEARATE SE1.5 g/50mL
  • WATER27.4065 mL/50mL
  • C12-20 ACID PEG-8 ESTER2.25 g/50mL
  • OXYBENZONE2 g/50mL
  • DECYL OLEATE1.9996 g/50mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]; Skin Barrier Activity [PE]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
83021-750-508302107505050 mL in 1 JAR (83021-750-50)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 83021-750 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83021-750 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83021-750. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.